POST LEONARD E — SEC insider filings

SEC reporting owner CIK 1235862. 36 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-09-17 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CG Oncology, Inc. (CGON)Director23—23 legs · 34,000 sh · $1,714,89745
uniQure N.V. (QURE)Director12—6 legs · 9,802 sh · $159,91315
Fulgent Genetics, Inc. (FLGT)Director1——1

Insider filings — POST LEONARD E

FiledFormIssuerReported transactionsSource
2026-11-174CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $92 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-10-194CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 500 @ $61.65 · Sale (S): 500 @ $62.48 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-09-174CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $72.98 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-08-184CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $74.54 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-07-174CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $71.17 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-06-254CG Oncology, Inc. (CGON)Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $70 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-06-234CG Oncology, Inc. (CGON)Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $65 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-06-124uniQure N.V. (QURE)Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0EDGAR
2026-06-054CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $54.50 · Option exercise (M): 1,000 (derivative) @ $0 · Grant/award (A): 9,354 (derivative) @ $0EDGAR
2025-11-184CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $41.43 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-10-154CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $43.25 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-10-014CG Oncology, Inc. (CGON)Option exercise (M): 5,000 @ $0.60 · Sale (S): 5,000 @ $40.09 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-09-164CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $35.10 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-09-044CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-07-184CG Oncology, Inc. (CGON)Option exercise (M): 2,000 @ $0.60 · Sale (S): 2,000 @ $28 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2025-06-244uniQure N.V. (QURE)Sale (S): 2,112 @ $14.45EDGAR
2025-06-134uniQure N.V. (QURE)Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0EDGAR
2025-06-064CG Oncology, Inc. (CGON)Grant/award (A): 24,165 (derivative) @ $0EDGAR
2025-05-224CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-04-294CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $30.76 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-03-184CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-02-194CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28.61 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2025-01-144CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $29.66 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2024-12-174CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 1,000 @ $28.84 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2024-12-064CG Oncology, Inc. (CGON)Option exercise (M): 1,000 @ $0.60 · Sale (S): 750 @ $34.40 · Sale (S): 250 @ $34.98 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2024-10-074CG Oncology, Inc. (CGON)Grant/award (A): 15,600 (derivative) @ $0EDGAR
2024-06-214uniQure N.V. (QURE)Grant/award (A): 8,080 @ $0 · Grant/award (A): 15,840 (derivative) @ $0EDGAR
2024-06-184uniQure N.V. (QURE)Sale (S): 2,222 @ $5.14EDGAR
2023-06-204uniQure N.V. (QURE)Grant/award (A): 8,700 @ $0 · Sale (S): 2,291 @ $18.83 · Grant/award (A): 17,060 (derivative) @ $0EDGAR
2023-03-014uniQure N.V. (QURE)Sale (S): 389 @ $19.73EDGAR
2022-08-034Fulgent Genetics, Inc. (FLGT)Grant/award (A): 8,000 @ $0EDGAR
2022-06-174uniQure N.V. (QURE)Grant/award (A): 9,080 @ $0 · Grant/award (A): 17,810 (derivative) @ $0EDGAR
2022-03-024uniQure N.V. (QURE)Sale (S): 795 @ $16.64EDGAR
2022-02-284uniQure N.V. (QURE)Grant/award (A): 1,534 @ $0 · Grant/award (A): 2,645 (derivative) @ $0EDGAR
2021-03-014uniQure N.V. (QURE)Grant/award (A): 2,382 @ $0 · Grant/award (A): 4,107 (derivative) @ $0EDGAR
2020-09-174uniQure N.V. (QURE)Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1235862 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs